Shaafici Pharmaceutical Import Co. (Shafco)

SHAAFICI PHARMACEUTICAL IMPORT CO. (SHAFCO) Shaafici Pharmaceutical Import Co., operating under the shortened name Shafco, is a trading company based in Lewes, Delaware, United States. The company operates primarily in pharmaceutical import and wholesale distribution, though its registered business scope extends across multiple sectors including manufacturing, food and hospitality services, and other service categories. BUSINESS OPERATIONS Shafco functions as an import and wholesale trader, indicating its core business involves sourcing pharmaceutical products and related goods for distribution within the United States market. The company maintains a workforce in the 500-1,000 employee range, suggesting a mid-sized operation capable of handling significant import volumes and distribution logistics. CREDIBILITY SIGNALS The company holds Certified V17 status, as observed by Reevol through the Atlas database. This certification indicates compliance with relevant regulatory or industry standards, though specific details regarding the issuing body and certification scope are limited in available sources. PUBLIC FOOTPRINT AND TRANSPARENCY Information regarding Shafco's year of establishment, official website, and detailed export markets is not available. The company has not established a prominent digital presence through a publicly listed website, which limits independent verification of operational details and product offerings. No participation in major industry trade fairs has been recorded in available data. BUYER CONSIDERATIONS Buyers evaluating Shafco should note that the company's visibility score of 0 indicates minimal public-facing information infrastructure. This presents challenges for independent due diligence. While the company's employee count and business registration suggest established operations, the lack of verifiable public information - including website, founding date, and specific certifications details - warrants additional verification before establishing supplier relationships. The pharmaceutical import sector is heavily regulated, and buyers should independently verify that Shafco maintains all required licenses, permits, and compliance certifications necessary to import and distribute pharmaceutical products in relevant jurisdictions. Standard supplier evaluation practices, including reference checks and regulatory compliance verification, are recommended given the limited publicly available information. RECOMMENDATION FOR FURTHER INVESTIGATION Prospective buyers should request documentation of all relevant pharmaceutical import licenses, DEA registration (if applicable), FDA compliance certifications, and references from existing distribution partners. Direct contact with the company to clarify its specific product portfolio, certifications, and market focus is advisable before proceeding with commercial discussions.